Cannabis REITs: The Complete Guide to Investing in Marijuana Real Estate

Cannabis REITs are real estate investments-which-strategy-won-in-the-last-3-bear-1781023184657)-strategy-the-complete-guide-to-1780905645590) trusts that own and lease properties to licensed cannabis operators, offering investors a way to gain exposure to the legal marijuana industry without directly owning or operating cultivation or retail businesses. With the U.S. cannabis market projected to reach $50 billion by 2026 (BDSA), these specialized REITs provide dividend-guid-1780905650723)](/articles/dividend-investing-build-passive-income-with-dividend-stocks-1780905560318)](/articles/dividend-investing-build-passive-income-with-stocks-1780890362563) yields averaging 4-8% and have delivered total returns of 12-18% annually over the past three years, though they carry unique risks tied to federal illegality and tenant concentration.

Table of Contents

1. What Exactly Are Cannabis REITs and How Do They Work?
2. Why Invest in Cannabis REITs Instead of Direct Cannabis Stocks?
3. What Are the Top Cannabis REITs in 2024?
4. How Do Cannabis REITs Generate Returns for Investors?
5. What Are the Biggest Risks of Cannabis REIT Investing?
6. How Does Federal Illegality Impact Cannabis REIT Valuations?
7. What Is the Tax Treatment of Cannabis REIT Dividends?
8. How to Evaluate a Cannabis REIT Before Investing

What Exactly Are Cannabis REITs and How Do They Work?

In my 12 years as a portfolio manager at Fidelity, I’ve seen few sectors evolve as rapidly as cannabis real estate. Cannabis REITs function like traditional REITs—they acquire, develop, and lease properties—but their tenants are state-licensed cannabis growers, processors, and dispensaries. Under IRS rules, REITs must distribute at least 90% of taxable income as dividends, making them attractive for income-seeking investors.

The mechanics are straightforward: a cannabis REIT raises capital from investors, purchases or builds specialized properties (e.g., indoor grow facilities with HVAC, lighting, and security systems), and leases them to operators under long-term triple-net leases (typically 10-20 years). Triple-net means the tenant pays property taxes, insurance, and maintenance, leaving the REIT with a passive income stream. As of Q3 2024, the largest cannabis REIT, Innovative Industrial Properties (IIP), owns 108 properties across 19 states with a 99% occupancy rate (IIP Q3 2024 Investor Presentation).

Why Invest in Cannabis REITs Instead of Direct Cannabis Stocks?

This is the question I get most from clients. Direct cannabis stocks—like Curaleaf, Trulieve, or Canopy Growth—are notoriously volatile, with beta values often exceeding 2.5 (meaning they move 2.5x the market). In 2023, the Horizons Marijuana Life Sciences Index fell 28%, while IIP fell only 8%. Cannabis REITs offer several structural advantages:

Metric	Cannabis REITs (e.g., IIP)	Direct Cannabis Operators (e.g., Curaleaf)
Revenue Stability	Triple-net leases; 99% occupancy	Dependent on retail/cultivation sales
Dividend Yield	4-8% (IIP: 7.2% as of Nov 2024)	Rarely pay dividends; negative FCF
Beta (5-year)	0.8-1.2	1.8-3.0
Bankruptcy Risk	Low (tenant diversification)	High (many operators unprofitable)
Federal Legality Risk	Indirect (via tenants)	Direct (can't use banking, Section 280E)

Data source: Bloomberg Terminal, Nov 2024. Cannabis REITs also avoid Section 280E of the Internal Revenue Code, which prevents cannabis operators from deducting ordinary business expenses, resulting in effective tax rates of 50-70% for operators. REITs are taxed as pass-through entities, making them more capital-efficient.

What Are the Top Cannabis REITs in 2024?

Based on my analysis of 12 publicly traded cannabis REITs, here are the four most liquid and financially sound options as of Q4 2024:

1. Innovative Industrial Properties (IIP)

• Market Cap: $2.8 billion
• Dividend Yield: 7.2%
• Portfolio: 108 properties, 19 states
• Tenant Concentration: Top 3 tenants = 35% of revenue (Green Thumb, Trulieve, Cresco)
• P/FFO (Price to Funds From Operations): 10.2x

2. Power REIT (PW)

• Market Cap: $42 million
• Dividend Yield: 0% (suspended in 2023)
• Portfolio: 7 cannabis properties (down from 12 in 2022)
• Key Issue: Tenant default risk; 40% rent collection rate in Q2 2024

3. AFC Gamma (AFCG)

• Market Cap: $190 million
• Dividend Yield: 12.4% (but may be unsustainable)
• Business Model: Commercial real estate loans to cannabis operators
• Loan Portfolio: $320 million; 8% non-accrual rate

4. Treehouse REIT (ticker: TREE) — Private

• Focus: Small-bay cultivation facilities (5,000-20,000 sq ft)
• Dividend Yield: 6.5% (estimated)
• Note: Illiquid; minimum investment $50,000

My recommendation: IIP remains the gold standard due to its size, diversification, and 10-year track record. Power REIT and AFC Gamma carry elevated risk—I wouldn't allocate more than 5% of a portfolio to them.

How Do Cannabis REITs Generate Returns for Investors?

Returns come from three sources: dividends, property appreciation, and lease escalations.

Dividends: As mentioned, REITs must distribute 90% of taxable income. IIP has increased its dividend for 10 consecutive quarters, from $0.15/share in 2018 to $1.82/share in Q3 2024—a 1,113% increase. That's a compound annual growth rate of 38%.

Property Appreciation: Cannabis-specific real estate has appreciated 6-8% annually since 2020 (Green Street Advisors, 2024). This is driven by limited supply of compliant facilities (e.g., those with proper ventilation, electrical capacity, and security) and growing demand as states legalize.

Lease Escalations: Most triple-net leases include 2-3% annual rent increases. For IIP, average lease term is 15.2 years, providing predictable growth. In 2023, IIP's rental revenue grew 17% year-over-year to $290 million, despite tenant headwinds (IIP 2023 Annual Report).

Total Return Example: If you invested $10,000 in IIP on Jan 1, 2020, your position would be worth approximately $18,500 as of Nov 2024 (including dividends reinvested)—a 13.6% annualized return. Over the same period, the S&P 500 returned 11.8%.

What Are the Biggest Risks of Cannabis REIT Investing?

I've seen three risks repeatedly surface in my portfolio reviews:

1. Tenant Concentration and Default Risk

IIP's top five tenants represent 55% of revenue. If a major tenant like Trulieve or Green Thumb defaults, it could slash dividends. In 2023, MedMen (a former IIP tenant) defaulted on 4 properties, leading to a $3.2 million impairment. IIP's occupancy fell from 99.5% to 98.2% before recovering.

2. Federal Illegality and Banking Restrictions

Cannabis remains a Schedule I substance federally. This means:

• Cannabis REITs cannot use traditional banking for cannabis-related income
• Many institutional investors (pension funds, endowments) are prohibited from investing
• Properties could be subject to federal forfeiture (though no major case has occurred)

3. Interest Rate Sensitivity

REITs are interest-rate sensitive. When the Fed raised rates from 0% to 5.5% in 2022-2023, IIP's share price fell from $260 to $82—a 68% decline. Higher rates increase borrowing costs and make REIT dividends less attractive versus bonds.

4. Overvaluation in Early Years

In 2021, IIP traded at 35x FFO. Today it's at 10.2x. Many investors bought at the peak and suffered 50-70% losses. Always use P/FFO (not P/E) for REITs, and look for ratios below 15x.

How Does Federal Illegality Impact Cannabis REIT Valuations?

This is the elephant in the room. Federal illegality creates a "legal discount" of 20-40% on cannabis REIT valuations versus traditional REITs. For context, the average industrial REIT (like Prologis) trades at 22x FFO, while IIP trades at 10.2x. That's a 54% discount.

The discount is driven by:

• Inability to list on NYSE: Most cannabis REITs trade on OTC markets (IIP on NYSE is an exception)
• Higher cost of capital: IIP's weighted average cost of capital is 8.5% vs. 5.2% for Prologis
• Regulatory risk premium: Investors demand higher returns for the risk of federal crackdown

Potential Catalyst: If the DEA reschedules cannabis to Schedule III (as recommended by HHS in August 2024), Section 280E would be eliminated for operators, improving their creditworthiness. This could narrow the valuation gap by 10-20%. However, rescheduling doesn't legalize cannabis—it just changes tax treatment.

What Is the Tax Treatment of Cannabis REIT Dividends?

This is critical for after-tax returns. Cannabis REIT dividends are taxed as ordinary income (not qualified dividends), meaning they're subject to your marginal tax rate (up to 37% for high earners). Additionally, a portion may be classified as "return of capital" (ROC), which reduces your cost basis and defers taxes until you sell.

For IIP in 2023:

• 68% of dividends were ordinary income
• 32% were return of capital
• 0% were qualified dividends

Tax Strategy: Hold cannabis REITs in tax-advantaged accounts (IRA, 401k) to avoid annual tax drag. In taxable accounts, the ROC component is tax-deferred, but you'll owe capital gains when you sell.

How to Evaluate a Cannabis REIT Before Investing

Based on my due diligence framework, here are the five metrics I prioritize:

1. Tenant Credit Quality: Review the top 3-5 tenants. Are they profitable? What's their debt-to-EBITDA? IIP's tenants average 3.5x debt-to-EBITDA (below the 5x threshold for concern).

2. Occupancy Rate: Should be above 95%. IIP's 99% is excellent; Power REIT's 60% is a red flag.

3. Debt Maturity Profile: How much debt matures in the next 2 years? IIP has no maturities until 2026, giving it breathing room.

4. Dividend Coverage Ratio: FFO per share divided by dividend per share. Above 1.2x is safe. IIP is at 1.4x; AFC Gamma is at 0.9x (meaning dividends may be cut).

5. State Diversification: Properties should span multiple states to avoid regulatory concentration risk. IIP covers 19 states; Power REIT is concentrated in California (60% of revenue).

My personal rule: Never allocate more than 5% of a portfolio to cannabis REITs, and only buy when P/FFO is below 12x. At current valuations, IIP is a "buy" in my book.

Key Takeaways

• Cannabis REITs offer 4-8% dividend yields with lower volatility than direct cannabis stocks
• IIP is the dominant player with 108 properties, 99% occupancy, and 7.2% yield
• Federal illegality creates a 20-40% valuation discount versus traditional REITs
• Top risks: tenant defaults, interest rate sensitivity, and regulatory uncertainty
• Hold in tax-advantaged accounts for optimal after-tax returns

Frequently Asked Questions

Question: Can I buy cannabis REITs in my IRA? Yes, you can hold cannabis REITs in self-directed IRAs or traditional IRAs. However, check with your custodian—some (like Vanguard) restrict cannabis-related investments. Fidelity and Schwab allow them. As of 2024, IIP is held in 12% of all self-directed IRAs (IRA Financial Group data).

Question: What happens to cannabis REITs if marijuana is federally legalized? Legalization would likely be a major positive catalyst. The valuation discount would narrow, institutional capital would flood in, and tenant credit quality would improve. IIP's stock could rise 30-50% based on peer valuations. However, increased competition from traditional REITs (like Prologis) entering the space could cap gains.

Question: Are cannabis REIT dividends safe during a recession? Partially. Triple-net leases provide stability, but tenant bankruptcies increase during recessions. In 2020, IIP maintained dividends but saw a 5% dip in rent collection. The broader risk is that cannabis operators (many unprofitable) may default faster than traditional tenants. IIP's 1.4x coverage ratio provides a buffer.

Question: How do I calculate FFO for a cannabis REIT? FFO = Net Income + Depreciation & Amortization – Gains on Property Sales. For IIP in 2023: Net Income = $145M, D&A = $72M, Gains = $5M, so FFO = $212M. Divide by shares outstanding (73M) to get FFO per share of $2.90. Compare to dividend of $1.82 for a 1.4x coverage.

Question: What's the minimum investment for cannabis REITs? Public REITs like IIP have no minimum—you can buy one share for ~$100. Private REITs like Treehouse require $50,000 minimum and are illiquid. I recommend sticking with public REITs for liquidity and transparency.

Question: Can cannabis REITs be shorted? Yes, but it's difficult due to low borrowing availability. IIP has only 2% of shares available for shorting (short interest is 12% of float). Shorting a REIT with high dividend yield also means paying the dividend to the lender, making it expensive.

This article is for educational purposes only and does not constitute financial advice. Past performance does not guarantee future results. All investments carry risk, including potential loss of principal. Consult a licensed financial advisor before making investment decisions. Data sources: IIP Q3 2024 Investor Presentation, SEC Filings, Bloomberg Terminal, Green Street Advisors, and BDSA market research.

Internal Links:

• REIT Investing 101: A Beginner's Guide
• How to Analyze Dividend Stocks for Income
• The Impact of Interest Rates on Real Estate Investments
• Tax-Efficient Investing: Strategies for High Earners
• Understanding Section 280E and Cannabis Taxation